BX Swiss TOP 30 CHF
1.401,10
PKT
+2,87
PKT
+0,21
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.06.05 | Novartis neutral | Bank Sarasin & Cie | |
| 06.06.05 | Sonova | Die Actien-Börse | |
| 03.06.05 | Zurich Insurance | DZ-Bank | |
| 06.06.05 | Novartis buy | Merrill Lynch | |
| 03.06.05 | Novartis | Der Aktionärsbrief | |
| 07.06.05 | Roche buy | Jyske Bank | |
| 03.06.05 | Novartis neutral | Bank Sarasin & Cie | |
| 02.06.05 | UBS | Zürcher Kantonalbank | |
| 02.06.05 | Novartis above average | Caris & Company | |
| 01.06.05 | Swiss Life kaufen | Conrad Hinrich Donner | |
| 01.06.05 | Roche | Der Aktionär | |
| 01.06.05 | Novartis Above Average | Caris & Company | |
| 27.05.05 | Zurich Insurance kaufen | DZ-Bank | |
| 27.05.05 | Roche buy | Bank Sarasin & Cie | |
| 27.05.05 | Roche kaufen | Berenberg Bank | |
| 27.05.05 | Adecco SA buy | Bank Sarasin & Cie | |
| 30.05.05 | Novartis buy | Jyske Bank | |
| 30.05.05 | Roche buy | Jyske Bank | |
| 07.06.05 | Swiss Life Kaufen | Conrad Hinrich Donner | |
| 27.05.05 | Adecco SA outperform | Goldman Sachs | |
| 27.05.05 | UBS buy | Bank Sarasin & Cie | |
| 24.05.05 | Roche overweight | JP Morgan | |
| 26.05.05 | Roche overweight | JP Morgan | |
| 24.05.05 | UBS buy | Bank Sarasin & Cie | |
| 26.05.05 | UBS buy | Bank Sarasin & Cie | |
| 23.05.05 | Swiss Life buy | M.M. Warburg | |
| 23.05.05 | Roche | Euro am Sonntag | |
| 26.05.05 | Roche | Euro am Sonntag | |
| 23.05.05 | Novartis | JRC | |
| 26.05.05 | Novartis | JRC | |
| 07.06.05 | Roche | Bank Hofmann | |
| 24.05.05 | Swiss Life kaufen | Nord LB | |
| 26.05.05 | Swiss Life kaufen | Nord LB | |
| 20.05.05 | Zurich Insurance | DZ-Bank | |
| 20.05.05 | Swiss Life buy | Smith Barney Citigroup | |
| 20.05.05 | Swiss Life buy | Smith Barney Citigroup | |
| 24.05.05 | Roche buy | Jyske Bank | |
| 26.05.05 | Roche buy | Jyske Bank | |
| 21.09.05 | Swiss Life | Nord LB | |
| 20.05.05 | Swiss Life | Nord LB |